112 
HR 2829 RFS 
sponse in order to prevent methamphetamine production 
and precursor diversion. 
(c) INTERNATIONAL AGREEMENTS.—The Director 
shall encourage the negotiation, drafting, and ratification 
of multilateral or bilateral agreements that may contain 
information-sharing treaties concerning provisions for pre-
cursor importation and exportation and additional provi-
sions for annual assessments of medical and scientific 
needs of each signatory country. 
(d) MATTERS ADDRESSED BY THE SUMMIT.—The 
summit may address the following: 
(1) The greater involvement of international po-
licing and customs organizations, such as Interpol, 
the United Nations Office on Drugs and Crime, and 
the World Customs Organization. 
(2) Expanding resources and hired persons to 
track 
international 
shipments 
of 
ephedrine, 
pseudoephedrine, and other precursor substances as 
controlled by the International Narcotics Control 
Board. 
(3) Working with the private sector and Fed-
eral agencies, as well as the World Health Organiza-
tion, to support the research and development of 
substances that can effectively replace primary pre-
cursors used in the manufacture of synthetic drugs. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00112
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
113 
HR 2829 RFS 
(e) DEADLINE.—The Director shall seek to convene 
the summit not later than 12 months after the date of 
the enactment of this Act and follow-up summits in subse-
quent years as the Director finds necessary. 
(f) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to the Director 
$1,000,000 to carry out this section. 
SEC. 21. STUDY ON DRUG COURT HEARINGS IN NONTRADI-
TIONAL PLACES. 
(a) FINDING.—Congress finds that encouraging drug 
courts and schools to enter into partnerships that allow 
students to see the repercussions of drug abuse by non- 
violent offenders may serve as a strong deterrent and pro-
mote demand reduction. 
(b) STUDY.—The Director of the Office of National 
Drug Control Policy shall conduct a study on drug court 
programs that conduct hearings in nontraditional public 
places, such as schools. At a minimum, the study shall 
evaluate similar programs in operation, such as the pro-
gram operated in the Fourth Judicial District Drug 
Court, in Washington County, Arkansas. 
(c) REQUIREMENT.—At the same time the President 
submits to Congress the National Drug Control Strategy 
due February 1, 2007, pursuant to section 706 of the Of-
fice of National Drug Control Policy Reauthorization Act 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00113
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
114 
HR 2829 RFS 
of 1998, the President shall submit to Congress a report 
on the study conducted under subsection (b). The report 
shall include an evaluation of the results of the study and 
such recommendations as the President considers appro-
priate. 
(d) DEMAND REDUCTION.—In this section, the term 
‘‘demand reduction’’ has the meaning provided in section 
702(1) of the Office of National Drug Control Policy Re-
authorization Act of 1998 (21 U.S.C. 1701(1)). 
SEC. 22. REPORT ON GOVERNMENT-SPONSORED METH-
AMPHETAMINE CONFERENCE. 
(a) REPORT.—Not later than 30 days after the date 
of the enactment of this Act, the Director of the Office 
of National Drug Control Policy shall submit to Congress 
a report explaining the rationale and circumstances lead-
ing to the sponsorship by the Department of Health and 
Human Resources, and the participation by employees of 
such department, in a conference conducted by the Harm 
Reduction Coalition and the Harm Reduction Project on 
August 19th and 20th, 2005, in Salt Lake City, Utah, 
titled the ‘‘1st National Conference on Methamphetamine, 
HIV, and Hepatitis Science & Response’’. 
(b) ADDITIONAL MATTERS COVERED.—The report 
shall include a description of the management and report-
ing systems of the Office of National Drug Control Policy 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00114
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
115 
HR 2829 RFS 
that are in place or that will be put in place to ensure 
that the policy of the Federal Government is consistently 
supportive of efforts to prevent the use of methamphet-
amine. 
SEC. 23. STUDY ON PRESCRIPTION DRUGS ASSOCIATED 
WITH IATROGENIC ADDICTION. 
(a) IN GENERAL.—The Director of the Office of Na-
tional Drug Control Policy shall request the Institute of 
Medicine of the National Academy of Sciences to enter 
into an agreement under which the Institute agrees to con-
duct a study examining certain aspects of prescription 
drugs associated with iatrogenic addiction, including 
oxycodone hydrochloride controlled-release tablets. 
(b) REQUIREMENTS.—The study conducted pursuant 
to this section shall evaluate— 
(1) the rate and impact of iatrogenic addiction 
associated with the use of prescription drugs de-
scribed in subsection (a); and 
(2) the relative addictiveness of prescription 
drugs described in subsection (a) when compared 
with other opioids and other substances included in 
schedule I or II of the schedules of controlled sub-
stances established by section 202 of the Controlled 
Substances Act (21 U.S.C. 812). 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00115
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
116 
HR 2829 RFS 
(c) REPORT.—The Director of the Office of National 
Drug Control Policy shall ensure that the agreement 
under subsection (a) provides for the submission of a re-
port to the Congress, not later than one year after the 
date of the enactment of this Act, on the results of the 
study conducted pursuant to this section. 
SEC. 24. REPORT ON TRIBAL GOVERNMENT PARTICIPA-
TION IN HIDTA PROCESS. 
(a) REPORT REQUIREMENT.—The Director of the 
Office of National Drug Control Policy shall prepare a re-
port for Congress on the representation of tribal govern-
ments in the High Intensity Drug Trafficking Areas Pro-
gram and in high intensity drug trafficking areas des-
ignated under that Program. The report shall include— 
(1) a list of the tribal governments represented 
in the Program and a description of the participa-
tion by such governments in the Program; 
(2) an explanation of the rationale for the level 
of representation by such governments; and 
(3) recommendations by the Director for meth-
ods for increasing the number of tribal governments 
represented in the Program. 
(b) DEADLINE.—The report prepared under sub-
section (a) shall be submitted not later than 1 year after 
the date of the enactment of this Act. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00116
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS